Earnings call transcript: Milestone Scientific Q3 2026 revenue misses forecast

Milestone Scientific, a company listed on NYSE under the ticker symbol MLSS, announced their third quarter earnings, reporting an EPS of -$0.0100, matching the expected -$0.0100. However, their revenue for the quarter amounted to $2.21M, which was below the anticipated $2.41M. Looking ahead to the fiscal year 2026, Milestone Scientific anticipates revenue between $9.8000M and $10.2000M, slightly below the analyst consensus of $9.9700M.

As of the latest close, the company's stock price stood at $0.29, reflecting a substantial decline of -40.5700% over the past three months and -12.1200% over the last year. Milestone Scientific experienced both positive and negative EPS revisions within the last 90 days. The latest data from InvestingPro indicates the company's financial health as "fair," and investors can explore further details on the company's recent earnings performance and financials through Investing.com's earnings calendar.